T uberculosis is an infection that has plagued mankind for millennia. It remains a leading cause of death worldwide and was implicated in an estimated 1.6 million fatalities in 2005 (ref. 1) . A substantial obstacle to the development of new diagnostics, drugs and vaccines is the lack of tuberculosis-specific probes that can be used to rapidly assess infection and monitor response to treatment 2 . The cell envelope of M. tuberculosis poses a significant permeability barrier that contributes to the intrinsic difficulties in eradicating this disease as it effectively precludes entry of most substances (including potential drugs and probes) to the bacterial cytoplasm 3 . The nonmammalian, disaccharide sugar trehalose (1, Fig. 1a ) is synthesized by M. tuberculosis through three independent pathways, and genetic knockouts of any of these three pathways results in either nonviable M. tuberculosis or organisms showing growth defects 4, 5 . Because of this essentiality, targeting the trehalose pathway may be an important approach to tuberculosis drug development. Trehalose is found in the outer portion of the mycobacterial cell envelope along with the glycolipids trehalose dimycolate (TDM, Fig. 1a ) and trehalose monomycolate (TMM, Fig. 1a ) 6 . TMM and TDM are important glycolipids for M. tuberculosis, capable of inducing granuloma formation in the absence of infection 7 . Mycolic acids are long (C60-C90), cyclopropanated lipids found in the cell wall of M. tuberculosis, which are important for bacterial outer membrane structure, virulence and persistence within the host 8 . Trehalose is anchored into the mycobacterial cell wall as mono-(TMM) or di-(TDM) mycolates by the action of the extracellular proteins Ag85A, Ag85B and Ag85C. Although these proteins were long known to immunologists by virtue of their immunogenicity, their enzymatic activity was first described in 1982 as the active fraction of a cell-free extract from Mycobacterium smegmatis that was capable of synthesizing TDM 9 . Ag85A, Ag85B and Ag85C are the most abundantly secreted M. tuberculosis proteins in vitro, accounting for as much as 41% of the total protein in culture supernatant 10 . Individual knockouts of the genes that code for single members of the Ag85 family have significant effects on total cellular mycolic acid content 11 ; triple knockouts of the ag85ABC genes have not been reported in M. tuberculosis, presumably because they are not viable. Ag85 isoforms all catalyze the reversible transesterification reaction between two units of TMM, generating TDM and free trehalose (Fig. 1a) ; the reverse reaction also allows for direct esterification of trehalose. Ag85 can also covalently introduce mycolates into arabinogalactan to form the base polymer of the cell wall 11, 12 . Ag85A, Ag85B and Ag85C share high sequence and structural homology [13] [14] [15] , characterized by an α,β-hydrolase fold and a hydrophobic fibronectin-binding domain. Their active sites are highly conserved, featuring a histidine, aspartic acid or glutamic acid and serine catalytic triad, a hydrophobic tunnel for the lipids and two trehalose binding sites (Fig. 1b) . These characteristics suggest a transesterification mechanism analogous to that of serine hydrolases, in which the formation of a covalent serinemycolic acid enzyme intermediate is followed by attack from the 6-hydroxyl of trehalose 13 . Structural analysis (Fig. 1c) of trehalose bound to Ag85B suggested positions (C-4′ and C-2) on trehalose that were directed outward toward solvent and that might tolerate substitutions and yet retain activity as substrates for Ag85. Trehalose itself has been demonstrated to be a substrate of Ag85 (refs. 9,16) and its uptake and use by M. smegmatis has been observed 5, 17 . Although early observations 18 suggest the uptake of trehalose uptake into whole cells of M. tuberculosis, this has not been fully investigated, and the corresponding activities of trehalose analogs have not been explored.
We show here not only that Ag85A, Ag85B and Ag85C are sufficiently promiscuous to process a variety of trehalose analogs with good efficiency but that trehalose and trehalose-probe analogs are also efficiently anchored to M. tuberculosis. We have exploited this substrate tolerance by designing fluorescent trehalose probes that are processed by Ag85 and that allow fluorescent labeling of M. tuberculosis in a selective manner. Our findings arm tuberculosis biologists with the first fluorescent small-molecule probe to label M. tuberculosis not only in culture but also in infected macrophages. 
rESulTS

Exogenous trehalose is incorporated into Tmm and TDm
We first sought to conclusively demonstrate that trehalose is taken up by live cells of M. tuberculosis in vitro (Fig. 2) . Unlike its fastgrowing relative M. smegmatis, which has 28 sugar transporters, the genome of M. tuberculosis encodes only five sugar permeases, suggesting that extracellular trehalose might not be efficiently taken up by mycobacteria 17 . Extracellular incorporation of trehalose into TMM or TDM, on the other hand, would not require transport across the cell envelope. Using comparative radioprobes 14 C-acetate, 14 C-glycerol, 14 C-glucose and 14 C-trehalose, we measured uptake in pathogenic M. tuberculosis over 2 and 24 h time periods (Figs. 2a and Supplementary Results, Supplementary  Fig. 1 ). Trehalose uptake was significant, and the strongest band labeled by 14 C-trehalose comigrated with a band labeled by 14 C-acetate and comigrated with cold TMM.
14 C-trehalose also labeled a band that comigrated with TDM, although not labeled to the same extent as TMM. To confirm that these bands were TMM and TDM, we also labeled cells after treatment with isoniazid (INH), which inhibits mycolic acid biosynthesis and therefore blocks production of both TMM and TDM 19 . INH effectively blocks biosynthesis of these two bands (see Fig. 2c (lane iii) ). Together these results demonstrated that trehalose is taken up by the bacteria and incorporated into TDM and TMM by M. tuberculosis in vitro ( Fig. 2c and Supplementary Fig. 2) .
M. tuberculosis is thought to infect the alveolar macrophages that line the lung epithelium; macrophage uptake therefore represents an additional permeability hurdle that separates any potential probe from M. tuberculosis 20 . We therefore labeled M. tuberculosis-infected J774 cells (a mouse macrophage-like cell line) and separately analyzed the macrophage supernatant, crude lysate and insoluble fractions (Fig. 2b) of both infected and uninfected cells. Not only did 14 C-trehalose successfully penetrate and internalize into mouse macrophages, it was also subsequently taken up by M. tuberculosis growing within these cells, thereby validating the potential of trehalose probes in vivo.
Design and synthesis of a trehalose analog library
To fully explore the potential of trehalose analogs as possible selective probes of M. tuberculosis, we designed and synthesized (see Supplementary Methods for details) a panel of compounds (Fig. 3) that would allow us to evaluate the substrate tolerance of Ag85 isoforms. This library of trehalose analogs featured systematic modifications at each position to explore the enzyme active site in detail. Such trehalose derivatives present unique synthetic challenges: creating the link between the two glucose units requires that two stereogenic centers with challenging configuration 21 be established simultaneously, and the symmetry of the trehalose scaffold itself necessitates potentially complex asymmetric modifications. Elegant intramolecular, aglycone-tethered glycosylation strategies (b-c) The X-ray crystal structure of ag85B suggests significant modification of trehalose substrates may be tolerated without altering binding contacts. ag85B binds trehalose (yellow) (pDB iD: 1F0p) 48 . (c) The active site of ag85B bound to trehalose. C-2 and C-4′ hydroxyls both point out of the active site. C-6 points into the hydrophobic tunnel (blue) that is thought to accommodate the long fatty acyl chains of the mycolic acids. Measurements to nearest residue are indicated in angstroms (pDB iD: 1F0p) 48 . A c
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(1) (8) have allowed access to some C-2 modifications and stereocontrol, yielding the α,α(1,1)-anomeric configuration found in natural trehalose, but are limited in their scope of diversification. Most previous modifications of the trehalose scaffold, including previously designed inhibitors of Ag85, have focused only on modifications at C- 6 and C-4 (refs. 23-25) .
Our trehalose-probe library was synthesized using complementary strategies for (i) directly creating the 1,1-linkage in trehalose and (ii) precise trehalose scaffold alteration (Supplementary Scheme 1), allowing access to analogs 2-22 bearing alterations in both the functional groups and in the stereochemical configurations found at all positions C-1, C-2, C-3, C-4 and C-6 in trehalose. Functional groups were chosen for incorporation that might later be useful in the design of imaging probes such as fluorine (2-F, 3-F, 4-F, 6-F derivatives) for potential use in 18 F-PET and amines for latestage attachment of chromophores, radiolabels and fluorophores.
1,1-linkage formation was accomplished in three ways: (i) ketoside formation 26, 27 , (ii) dehydrative glycosylation 28 and (iii) chemoenzymatically 29 . Full characterization of the synthesized probes included unambiguous assignment of stereochemistry using NMR (NOE and H-1 coupling constants). Methyl ketosides and exo-glycals proved to be excellent reagents for α,α-selective synthesis of asymmetric trehalose from a wide range of modified coupling partners, including derivatives of glucose, 2-deoxy-2-fluoro-glucose, 3-deoxy-3-fluoro-glucose and 2-N-carbobenzyloxyamino-glucose, yielding trehalose analogs 2-7 in good overall yields (30-90%) after deprotection (see Supplementary Methods). Symmetric dideoxy 10, diiodo 12 and difluoro 13, 14 trehalose analogs were accessed through dehydrative dimerization reactions 28 . 2-Deoxy-2-fluoro-trehalose 22 was synthesized using a multistep enzymatic route. Finally, trehalose-scaffold modifications used regioselective protecting group manipulation 25 to allow selective asymmetric access and replacement of hydroxyl groups at positions 4 and 6 (see Supplementary Methods for full details). Together these synthetic routes allowed ready access to trehalose analogs 2-22 containing modifications such as 1-methyl 2-9, 2-fluoro 3, 5, 13, 14 and 22, 2-iodo 12, 2-deoxy 10 and 11, 3-fluoro 6, 4-fluoro 21, 6-fluoro 20, 6-bromo 19, 6-phosphate 15-17, 6-azido 18 and even stereoisomers 4, 5 and 11 and allowed access to intermediates such as 2-amino-trehalose 7 onto which imaging labels fluorescein (in 9), fluorobenzyl (in 8) and even quantum dots (in trehalose-QD, see Supplementary Methods) could be coupled.
A new assay of trehalose processing
The complete substrate specificity and a full kinetic analysis of the Ag85 enzymes has not previously been demonstrated, presumably because of the difficult nature of the radiochemical assay using natural substrates. Heterogeneity in the mycolic fatty acid chain length (C30-C90) and low solubility of both substrates and products in aqueous medium have complicated prior assays. The widely used 14 C-trehalose radioassay 16 monitors 14 C-trehalose radiolabel incorporation into TDM and TMM yielding, at best, approximate k cat(app) values; such assays have suggested that Ag85B has a lower (~20%) activity than Ag85A and Ag85C
16
. Mass spectrometric analysis 30 provided a rapid means to screen trehalose analogs 1-24 as substrates of all Ag85 isoforms (Table 1) . Ag85A, Ag85B and Ag85C were prepared and purified as previously described 16 (see Supplementary Methods and Supplementary  Figs. 3-8) . We designed an assay (see Supplementary Methods) based on the use of precise, homogeneous mono and dihexanoyl trehalose substrates, which proved to be water soluble and readily turned over by Ag85, allowing the development of a broad Ag85 substrate screen (Supplementary Scheme 2) . A calibrated green-amber-red 30 screen for catalysis of transfer of the acyl chain from natural trehalose to unnatural trehalose-analog (trehalose*) using these pure synthetic substrates allowed determination of relative reactivity ratios of trehalose*/trehalose (Table 1) . Notably, this screen revealed a strong selectivity for trehalose-like disaccharides over monosaccharides such as D-glucose (23) but a striking plasticity for all tested trehalose analogs. Modifications on every position of the sugar scaffold were tolerated, including even C-1 methyl groups at the crowded anomeric linkages in 2-9, positive charges, such as in the 2-amino-trehalose 7 and even stereochemically 'incorrect' 2,2′-di-fluoro-αβ-mannotrehalose 14. Even a previously reported inhibitor 16 , 6-azido-trehalose 18, and putative tetrahedral intermediate analogs, such as trehalose-6-phosphate 16, were also processed.
Prior reports of 18 as an inhibitor (albeit a weak one with a reported minimum inhibitory concentration (MIC) against a related mycobacterial species of 200 μg ml −1 ) 16 prompted us to examine the possibility that these analogs also induced growth inhibition; MIC analysis was therefore carried out on key representative compounds ( Table 1) . Among these only 2,2′-dideoxy-lyxo-trehalose 11, which was not a substrate for any of the three Ag85 isoforms, showed an inhibitory effect (MIC 100 μg ml −1 ). C-6-modified compounds that were processed well by Ag85 inhibited growth only at high concentrations (MIC 100-200 μg ml −1 ). Notably, no growth inhibition with FITC-trehalose was noted either in vitro or in infected macrophages (see Supplementary Fig. 9 ).
FITC-trehalose specifically labels M. tuberculosis in vitro
Next we explored the uptake of fluorescent probes in growing cells of M. tuberculosis (Fig. 4a, Supplementary Fig. 11) . The pathogenic M. tuberculosis strain H37Rv was grown for 24 h in the presence of FITC-trehalose and then washed to remove unbound dye. A significant increase in fluorescence over time was observed in bacteria exposed to FITC-trehalose, relative to the autofluorescence of the control bacteria and relative to heat-killed M. tuberculosis that had been treated with FITC-trehalose ( Supplementary  Figs. 10-12 ). Heat-killed M. tuberculosis form large aggregates that are particularly difficult to wash adequately, perhaps contributing to the relatively high background observed in these organisms. To demonstrate that incorporation was specific, we also monitored incorporation of FITC-glucose into live cells of M. tuberculosis and found significantly less incorporation of label into cells (Supplementary Fig. 10b) , consistent with the poor efficiency of glucose as a substrate for the Ag85 enzymes (and the unlikely uptake of this probe into the cell by glucose-specific transporters). To demonstrate that this incorporation was dependent upon Ag85, we obtained a mutant in Ag85C that has been previously reported to have 40% less mycolic acid incorporation into the mycobacterial cell wall 11 . This mutant incorporated approximately 30% less FITC-trehalose than did wild type (Supplementary Fig. 10a ), supporting our proposed mechanism of anchoring of FITC-trehalose through Ag85-mediated incorporation of mycolic acids. To unambiguously establish that FITC-trehalose was localizing to cells by virtue of being esterified with mycolic acids, we simultaneously labeled cells with both FITC-trehalose and 14 C-acetate and isolated individual fluorescent spots by preparative TLC (Fig. 2c) . We did not make any attempt to characterize the other less polar spots of low abundance that also apparently incorporated FITC-trehalose, although these might reasonably be supposed to be other trehalosecontaining glycolipids found within the mycobacterial cell wall 31, 32 . Compound numbers correspond to those in Figure 3 . FiTC-trehalose entry 9 is bolded. Substrate response is expressed as percentage of natural substrate response: >75%, dark green; 25-75%, light green; 5-25%, amber; <5%, red. (response = peak height (mono-Hex*)/peak height (trehalose*)). MiC, minimum inhibitory concentration; MiC 50 , concentration causing 50% growth inhibition; ND, not determined. † Has some growth inhibition at 200 μg ml.
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Saponification of these spots and subsequent methylation and TLC revealed that the strongly fluorescent spots carrying FITC-trehalose were associated with lipids comigrating with the characteristic triplet pattern of the three classes of mycolic acids (alpha, methoxy and keto) (Fig. 2d) . Finally, to establish specificity of labeling, we also exposed three other organisms commonly found in the human lung to FITC-trehalose: Staphylococcus aureus, Haemophilus influenzae and Pseudomonas aeruginosa. None of these organisms were found to show appreciable labeling with FITC-trehalose (Supplementary Fig. 10b ).
The value of FITC-trehalose as a probe was demonstrated by the clear patterns of differential accumulation within live M. tuberculosis (Fig. 4a-d, Supplementary Figs. 11-13 ).
For example, confocal fluorescence microscopy of H37Rv-M. tuberculosis expressing a red fluorescent protein (RFP, here mCherry, carried by a PMV261 plasmid) revealed higher levels of green fluorescence from FITC-trehalose incorporation at outer membranes and, in particular, at the bacterial poles, and less in mid sections (where the RFP localizes, Fig. 4c, Supplementary  Figs. 11-12 ). This specific polar localization was confirmed by microscopic sections along the Z-axis (Z-stacks, Supplementary  Fig. 11 ) and by statistical analysis of mean fluorescence (P < 0.0001, Fig. 4d ). These observations are not only consistent with the mode of action proposed for these trehalose analogs but also suggest higher Ag85 activities at the poles that are consistent with a polar growth model. 
FITC-trehalose labels M. tuberculosis macrophages
We next tested the ability of these probes to selectively label M. tuberculosis in mammalian cells during infection. Treatment of M. tuberculosis-infected macrophages with FITC-trehalose ( Fig. 4e-n) demonstrated that the probe was internalized into macrophages with subsequent labeling of the bacteria. The specificity of the label for M. tuberculosis was demonstrated by colocalization of staining with an M. tuberculosis-specific antibody (ab905, Supplementary Fig. 13 ), use of an alternative labeling strategy (Supplementary Fig. 14) and failure to observe labeling with FITC-glucose ( Supplementary  Fig. 15) . Labeling of the intra-macrophage bacteria was also effectively abolished by competing administration of high concentrations (10-100 mM) of trehalose (Supplementary Fig. 16 ).
In contrast to the fairly uniform labeling of bacilli observed in vitro, bacterial labeling in vivo was not uniform, either between cells or within a cell. We observed the same polar localization of label in in vivo-grown cells that was seen in the in vitro cells; however, some bacterial cells appeared to incorporate no label at all. By incorporating a constitutively expressed RFP in the infecting bacilli (either integratively transformed Mycobacterium bovis BCG expressing the DsRed1 gene 33 or the H37Rv-M. tuberculosis mCherry variant (see above), for comparison) we observed that even mycobacterial cells within a single macrophage showed very different labeling intensities (Fig. 4h-k) . We speculated that this differential FITC-trehalose labeling might be relevant to the growth status of a particular bacterium within the cell, reflective of the maturation status of the endosomal compartment within which they were located. TDM has been shown to inhibit fusion between vesicles 34 and is potentially responsible for the inhibition of phagosomal acidification by M. tuberculosis 35 . To test this hypothesis, mouse bone marrow macrophages (BMMs) were infected with RFP-expressing H37Rv and treated with FITC-trehalose, with or without activation by interferon-γ (IFN-γ). Colocalization studies were undertaken between the H37Rv and markers discriminating between endosomes, phagosomes and lysosomes, including the early endosome-associated antigen (EEA-1) 36 39) ). Colocalization was then assessed by confocal microscopy between these markers and the entire bacterial population as well as the highly FITC-trehalose-labeled subpopulation. As expected, low colocalization was observed both under activated and unactivated conditions for EEA-1 (Supplementary Fig. 18 ). Consistent with previous reports of accumulation of Rab5 in the mycobacterial phagosome, we observed consistent colocalization of this marker (Supplementary Fig. 19 ) with both total population of bacteria and high FITC-trehalose-labeled bacilli in unactivated macrophages.
Upon IFN-γ activation, however, Rab5 colocalization was found to be less for highly FITC-trehalose-labeled M. tuberculosis than the bulk bacterial population (Supplementary Fig. 19 ). Colocalization between Rab14 and FITC-trehalose-labeled M. tuberculosis compared to the total population of bacteria was comparable for both unactivated and IFN-γ-treated macrophages ( Supplementary  Fig. 20) . In contrast, procathepsin D, cleavage of which is a marker of phagosomal maturation and phago-lysosome fusion, was increased in colocalization with FITC-trehalose-positive M. tuberculosis relative to the whole population (Supplementary Fig. 21 ). LAMP-1 was also found to colocalize to a lesser degree with highly FITCtrehalose-positive bacteria (Fig. 4h-k) than the population average, particularly upon IFN-γ activation (Fig. 4k-n) . Together these data are consistent with the hypothesis that M. tuberculosis that poorly incorporate FITC-trehalose tend to be localized to Rab5-containing phagosomes that have more fully matured toward degradative lysosomes. The corollary is that those with high Ag85-activity that incorporate FITC-trehalose well and will therefore readily generate TDM are associated with less-developed phagosomes, perhaps through TDM-associated inhibitory mechanisms 34, 35 .
DISCuSSIoN
Despite decades of investigation for both their immunologic and enzymatic activities, the Ag85 enzymes remain poorly understood. Little is known about the range of their substrates and the reason for their apparent functional redundancy in M. tuberculosis. The uptake of 14 C-trehalose into M. tuberculosis in vitro as well as into infected macrophages suggested that trehalose analogs may be useful in designing new probes of tuberculosis pathogenesis. Using a new Ag85 substrate assay, we have found that Ag85A, Ag85B and Ag85C will tolerate surprisingly extensive modifications on the trehalose scaffold, processing many disaccharides well (but not monosaccharides).
The discovery of the breadth of substrates processed by Ag85 isoforms could have important implications for the biological roles of these enzymes. The enzyme-specific differences in substrate tolerance observed imply an unappreciated subtlety in the active site architecture of these enzymes. Numerous glycolipids within M. tuberculosis contain a trehalose core, including TDM, TMM, pentaacyl trehalose, triacyl trehalose and sulfolipid-1 (SL-1); little is known about the final acylation steps of pentaacyl trehalose, triacyl trehalose and SL-1, and the enzymes of the Ag85 complex have been postulated to be involved in the lipidation of these compounds 31, 32 . The substrate plasticity, particularly at the C-2 position, may also have implications in the final acylation steps of sulfolipid-1, which are unknown, but have been postulated to potentially occur via Ag85 (ref. 31 ). Glucose and arabinose, both of which have been proposed as native enzyme substrates, are processed, albeit poorly relative to trehalose dissacharides 11, 12, 40 . The ability to fluorescently label lipids attached to trehalose by the Ag85 proteins should be useful in identifying other pathways that may use their transesterification activity and in helping clarify this poorly understood area of biochemistry.
Most notably, these assays have informed the design of a fluorescent probe that selectively labels M. tuberculosis in infected macrophages. Prior imaging work with M. tuberculosis in infected macrophages has used several strategies 41, 42 , but none allow for nontoxic imaging of bacteria in vivo. Bacteria can be labeled with Texas Red through oxidation with sodium periodate before infection. However, these harsh labeling conditions are nonselective and would be expected to oxidize carbohydrates that may be structurally important as well as peripherally associated glycolipids that may be important for specific virulence attributes 41 . Fluorescently labeled vancomycin has been elegantly used to track the cell division patterns of M. smegmatis and M. bovis BCG 42 , but its toxicity toward M. tuberculosis 43 may affect experimental results. Antibodies can be used to label M. tuberculosis upon fixation and for enzyme-linked immunosorbant assays (ELISA) 44 but are not useful for live imaging. FITC-trehalose shows no significant inhibition of M. tuberculosis growth, which suggests that it does not perturb natural bacterial functions, thereby allowing imaging of healthy, viable bacteria. FITC-trehalose is also selective for M. tuberculosis and readily penetrates macrophages. Unlike other possible probes, its mode of action involves the activity of an enzyme unique to this genus of organisms. Given the highly conserved nature of the Ag85 proteins 45 in mycobacteria (and the complete absence of trehalose in mammalian biology), it is likely this probe would label nontuberculous mycobacteria as well as other members of the tuberculosis complex.
Our understanding of the macrophage infection process is incomplete 46 , so the ability to follow viable M. tuberculosis during infection shown here could prove extremely useful as a means to further understand the bacterial transit to the phagosome as well as other intracellular compartments. The colocalization studies between FITC-trehalose-labeled M. tuberculosis and various markers of phagosome maturation suggest that FITC-trehalose article NATurE ChEmICAl BIology doi: 10.1038/nchembio.539 may preferentially label those bacteria that resist acidification and phagosome-lysosome fusion. An alternative hypothesis that we cannot rule out is that incorporation of FITC-trehalose into the membrane of a subset of bacilli alters the course of development of their phagosome, as has been seen with Brucella pertusis prelabeled with FITC before infection 47 . In our study FITC-trehalose is added after the infection has been established and is in low concentration relative to TDM; we expect the influence of the FITC-trehalose-DM to be slight. Other trehalose-tagged molecules, potentially labeled at different positions or with different tags on the trehalose scaffold, may also prove useful as additional M. tuberculosis probes. Future work with FITC-trehalose and related compounds will hopefully shed more light on its in vivo potential as a possible diagnostic tool to label M. tuberculosis in an infected host. Perhaps more notably, the broad substrate tolerance of the Ag85 proteins suggests the possibility of probes based on such analogs for a diverse panel of imaging modalities.
mEThoDS
Chemical synthesis. The synthesis of all reported compounds is described in the Supplementary Methods.
Mass spectrometry. Full details are described in the Supplementary Methods. Briefly, a 96-well plate was set up with each well containing TDH 27 and one of the screen compounds in 1 mM TEA buffer (pH = 7.2) at 37 °C. To each well was added by automated injection (with mixing) 20 μl of either Ag85A, Ag85B, Ag85C or buffer alone to give final concentrations of 500 μM of each substrate and 2 μM of Ag85. The samples were incubated at 37 °C for 2 h 40 min before injection of a 10-μl aliquot directly into the mass spectrometer. The resulting mass spectra were measured in ESI-continuum mode (150-1,000 Da), corrected for baseline subtraction and smoothed. The peak intensities for monohexanoylated product and remaining substrate 26 were measured and the product/substrate ratio calculated for each well.
